Global Health Delivery

What Global Health Delivery does

Global Health Delivery, formally The Global Health Delivery Project, is a non-profit academic research initiative jointly operated by Brigham and Women's Hospital (Division of Global Health Equity) and Harvard T.H. Chan School of Public Health, founded in 2007 and headquartered in Boston, Massachusetts with 11-50 employees. The organization operates three interconnected pillars: (1) Digital Tools, including Better Evidence, which provides free clinical decision support and complimentary UpToDate subscriptions to frontline clinicians, and a Pandemic Response tool focused on vaccine delivery; (2) Cases and Research, comprising a library of case studies and publications on what works in healthcare delivery; and (3) Teaching Programs, anchored by the Global Health Delivery Intensive, an application-based course with tuition, faculty, and an alumni network. Reach is reported at 325,000+ clinicians impacted across 190 countries, with 40 million+ clinical decisions changed through its tools.

The business model is non-commercial. Tools and case studies are distributed free of charge via self-serve digital channels, while the primary revenue-bearing stream is tuition from the Global Health Delivery Intensive course. Underlying funding flows through Harvard institutional support, grants, and donations, and the organization has no disclosed external investors or venture funding. Distribution relies on digital platforms (LinkedIn, Facebook, YouTube, email newsletter) and partnerships, most notably a technology integration with UpToDate. Strategic partnerships with Brigham and Women's Hospital and Harvard University are core to operational capacity and brand credibility, while the UpToDate relationship is a content-access partnership rather than a co-development arrangement.

There is no evidence of proprietary AI/ML, no app products, no API offerings, and no certifications or compliance disclosures in the source material. The organization's competitive positioning rests on academic brand, clinical credibility, free access to curated evidence, and a global community of clinicians built through training programs.

Name

Global Health Delivery

Legal name

The Global Health Delivery Project

Website

http://www.globalhealthdelivery.org

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Global Health Delivery is a collaborative professional community investigating decisions of disease treatment and prevention.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Digital Health, Health Information Systems & Data Programs (BPADAIAJ)

akta.pro secondary industries

Data, Surveillance & Digital Public Goods Partnerships for Global Health (HLAJAOAN), Immunization & Vaccine Delivery Programs (BPADAIAB), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Clinical decision support
• Global health delivery
• Healthcare case studies
• Public health training
• Pandemic response tools

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Academic/Research Funding: As a joint initiative of Brigham and Women's Hospital and Harvard University, the organization operates as an academic research project likely funded through institutional support, grants, and donations rather than commercial revenue generation.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

The Global Health Delivery Project provides free digital clinical decision support tools (Better Evidence and Pandemic Response/Vaccine Delivery platforms), publishes research case studies on effective healthcare delivery practices, and runs structured training courses (the Global Health Delivery Intensive) for clinicians and global health professionals. The initiative bridges academic clinical evidence with real-world frontline practice across 190 countries.

Product overview

The Global Health Delivery Project is a joint initiative of Brigham and Women's Hospital and Harvard University that operates as a multi-component platform. It consists of three interconnected pillars: (1) Digital Tools including Better Evidence (free clinical decision support) and Pandemic Response (vaccine delivery support); (2) Cases and Research providing case studies documenting effective health care delivery practices; and (3) Teaching Programs featuring the Global Health Delivery Intensive course. These offerings work together to bridge the gap between evidence and real-world practice, facilitating free access to clinical decision support tools for current and future health workforce members, researching what works in healthcare delivery, and running training courses for global health professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Better Evidence A free digital clinical decision support tool that provides clinicians at the frontlines with evidence-based healthcare resources, including a free subscription to UpToDate, enabling better medical decisions using proven approaches and evidence.
• Pandemic Response (Vaccine Delivery) A digital tool focused on pandemic response and vaccine delivery initiatives, supporting health systems and clinicians in managing public health emergencies and vaccine rollout in resource-limited settings.
• Cases in Global Health Delivery A research collection of case studies documenting what works in healthcare delivery, used for research and educational purposes to advance the field of global health delivery and inform clinical practice.
• Global Health Delivery Intensive A structured training course for global health professionals with an application process, faculty, tuition and fees, and an alumni network, designed to build capacity and strengthen health systems to deliver high-quality, equitable, and value-based care.

Quantifiable outcome

• 325,000+ clinicians impacted worldwide
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Brigham and Women's HospitalcoreStrategic or Co-development PartnerBrigham and Women's Hospital is a co-founder and joint initiative partner of the Global Health Delivery Project, specifically through its Division of Global Health Equity. The hospital provides clinical expertise and operational infrastructure for the organization's global health delivery research and tools.
• Harvard UniversitycoreStrategic or Co-development PartnerHarvard University (through Harvard T.H. Chan School of Public Health) is a co-founder and joint initiative partner, providing academic rigor, research methodology, and institutional support to the Global Health Delivery Project.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• UpToDate (Wolters Kluwer): UpToDate is the leading commercial point-of-care clinical decision support tool. GHD's Better Evidence program essentially redistributes UpToDate to frontline clinicians, making Wolters Kluwer both GHD's core partner and the closest direct comparator in functionality and clinician audience.
• BMJ Best Practice: BMJ Best Practice is a global clinical decision support platform widely used by clinicians, including in LMICs through sponsored access programs. It directly competes with Better Evidence for clinician mindshare and shares GHD's model of combining point-of-care tools with professional development content.
• DynaMed (EBSCO): DynaMed is an evidence-based clinical decision support tool used at the point of care. It competes head-to-head with Better Evidence in serving clinicians globally and represents a comparable subscription-based reference product in the same category.

Broad incumbents

• World Health Organization (WHO) Digital Health & Learning: WHO publishes free digital clinical guidelines, decision-support tools, and learning resources aimed at frontline clinicians globally. It operates as a much larger institutional incumbent in the same digital public-good space where GHD's Better Evidence and Pandemic Response tools compete for adoption.
• Partners In Health: Partners In Health is a major non-profit focused on healthcare delivery in resource-limited settings, with deep academic and clinical roots (closely linked to Harvard/Brigham). It overlaps with GHD on global health delivery research, training, and frontline clinician engagement, though its core model is direct service delivery rather than digital tools.
• edX (Harvard/edX Global Health Programs): edX, founded by Harvard and MIT, hosts a large catalog of global health courses and professional certificates. It competes with GHD's Global Health Delivery Intensive for the same learner segment and represents a much larger incumbent in the online professional development category.
• Coursera (Global Health Specializations): Coursera hosts multiple global health specializations from leading universities and competes with GHD's teaching program for working professionals seeking global health credentials. It represents the mass-market incumbent in online professional education.

Emerging players

• OpenMRS: OpenMRS is an open-source medical record system widely deployed in LMIC health systems. While its primary function is EHR, it overlaps with GHD's mission of strengthening frontline care delivery and competes for institutional attention and clinician workflow in the same LMIC environments.
• DHIS2 (Health Information Systems Programme): DHIS2 is the dominant open-source health information system used by ministries of health across LMICs. It represents the institutional/Health-IT layer adjacent to GHD's clinical decision support focus and competes for the same donor and government budget envelopes.
• Global Health Corps: Global Health Corps is a non-profit leadership development organization placing emerging leaders in global health organizations. It overlaps with GHD's alumni/leadership pipeline mission and competes for the same fellowship and professional cohort audience.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ghdprojectatharvard
• Facebookfacebook.com/globalhealthdelivery
• LinkedInlinkedin.com/company/global-health-delivery-project
• Xx.com/ghdonline

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Health Delivery